Login / Signup

Age of onset and factors affecting treatment responses in ocular myasthenia gravis.

Parinee KemchoknateeAnyarak ArmornpetchsathapornDuanghathai TangonThansit Srisombut
Published in: International ophthalmology (2023)
A higher dose of pyridostigmine may be necessary for achievement of favorable treatment response. AChRAb seropositivity is a predictor for unfavorable treatment response in Thai populations.
Keyphrases
  • myasthenia gravis
  • combination therapy